Oyster Point Pharma Inc 's ability to collect accounts receivable sequentially worsen to 2.15, indicating more challenging environment then in the second quarter 2022, but still, it is a far cry from any concerns. Oyster Point Pharma Inc 's Accounts Receivable average collection period in the Sep 30 2022 quarter, has increased to 170 days, from 74 days, in the Jun 30 2022 quarter.

If we take a look into Healthcare sector 509 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio remained unchanged relative to the previous period at no. 3356.

What is Receivable Turnover Ratio?
What is Oyster Point Pharma Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

OYST Receivables Turnover Ratio	(Sep 30 2022) III. Quarter	(Jun 30 2022) II. Quarter	(Mar 31 2022) I. Quarter	(Dec 31 2021) IV. Quarter	(Sep 30 2021) III. Quarter
Y / Y Receivable Change	427.36 %	-	-	-	-
Y / Y Revenue Change	-68.84 %	-	-	-	-
Receivable Turnover Ratio (TTM)	2.15	4.95	7.32	10.72	28.71
OYST's Total Ranking	# 3356	# 3356	# 0	# 0	# 2632
Accounts Receivable average collection period days	170	74	50	34	13
Seq. Receivable Change	20.75 %	90.34 %	-13.82 %	166.24 %	-
Seq. Revenue Change	19.13 %	73.56 %	-59.01 %	-63.24 %	-

Receivable Turnover Company Ranking
Within:	No.
Biotechnology & Pharmaceuticals Industry	# 44
Healthcare Sector	# 510
Overall Market	# 3356

Receivable Turnover Ratio Statistics
High	Average	Low
0.17	0.15	0.12
(Jun 30 2022)		(Sep 30 2022)

OYST Company Profile • Back to OYST Efficiency Comparisons • Compare OYST Receivables Turnover Ratio to its Competitors

Financial Statements
Oyster Point Pharma Inc 's Accounts Receivable	$ 13 Millions	Visit OYST's Balance sheet
Oyster Point Pharma Inc 's Sales TTM	$ 20 Millions	Visit OYST's Income Statement
Sources of OYST's Revenues		Visit OYST's Sales by Geography

Other Accounts Receivable Turnover Ratios
Biotechnology & Pharmaceuticals Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
OYST's Receivable Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
OYST's Growth Rates	OYST's Roa	OYST's Inventory Turnover Ratio	OYST's Dividend Comparisons
OYST's Profitability Ratios	OYST's Roi	OYST's Asset Turnover Ratio	OYST's Dividend Growth
OYST's Valuation Ratios	OYST's Roe	OYST's Financial Strength Ratios	OYST's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Sep 30 2022, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Sep 30 2022	Receivable at quarter ending Sep 30 2022
Rapid Micro Biosystems Inc	4.08	$ 17.967 Millions	$ 4.400 Millions
Sunwin Stevia International Inc.	4.04	$ 33.998 Millions	$ 8.424 Millions
Rafael Holdings Inc	4.03	$ 2.124 Millions	$ 0.527 Millions
Bionik Laboratories Corp	4.01	$ 1.106 Millions	$ 0.276 Millions
Enanta Pharmaceuticals Inc	4.00	$ 86.160 Millions	$ 21.540 Millions
Inspiremd Inc	3.98	$ 5.299 Millions	$ 1.330 Millions
Bioventus Inc	3.97	$ 515.305 Millions	$ 129.864 Millions
Curis Inc	3.94	$ 10.410 Millions	$ 2.641 Millions
Pro dex Inc	3.93	$ 43.140 Millions	$ 10.990 Millions
Prophase Labs Inc	3.92	$ 145.980 Millions	$ 37.226 Millions
Athenex Inc	3.89	$ 119.706 Millions	$ 30.745 Millions
Kineta Inc	3.88	$ 4.845 Millions	$ 1.250 Millions
Pliant Therapeutics Inc	3.87	$ 9.719 Millions	$ 2.513 Millions
Innoviva Inc	3.85	$ 373.216 Millions	$ 97.063 Millions
Bellicum Pharmaceuticals Inc	3.81	$ 1.546 Millions	$ 0.405 Millions
Psychemedics Corporation	3.80	$ 25.973 Millions	$ 6.826 Millions
Signify Health Inc	3.75	$ 783.900 Millions	$ 209.300 Millions
Agile Therapeutics Inc	3.74	$ 8.402 Millions	$ 2.249 Millions
Barinthus Biotherapeutics Plc	3.71	$ 38.245 Millions	$ 10.314 Millions
Halozyme Therapeutics Inc	3.70	$ 580.623 Millions	$ 156.852 Millions
Paratek Pharmaceuticals Inc	3.70	$ 116.507 Millions	$ 31.483 Millions
Ligand Pharmaceuticals Incorporated	3.68	$ 241.673 Millions	$ 65.667 Millions
Eli Lilly And Company	3.66	$ 29,239.500 Millions	$ 7,982.525 Millions
Ironwood Pharmaceuticals inc	3.64	$ 420.527 Millions	$ 115.604 Millions
Royalty Pharma Plc	3.60	$ 2,247.167 Millions	$ 625.034 Millions
Scorpius Holdings inc	3.44	$ 6.916 Millions	$ 2.010 Millions
Progyny Inc	3.41	$ 700.145 Millions	$ 205.144 Millions
Luna Innovations Inc	3.40	$ 90.744 Millions	$ 26.723 Millions
Co diagnostics Inc	3.38	$ 53.218 Millions	$ 15.746 Millions
Biocept Inc	3.38	$ 45.539 Millions	$ 13.477 Millions

Date modified: 2026-08-29T17:41:26+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.